{
  "chapter": "Complex Electron Transport Chain",
  "questions": [
    {
      "q_no": 1,
      "question": "In red blood cells under low energy states, which of the following best describes the fate of pyruvate?",
      "options": {
        "A": "Converted to acetyl-CoA to enter the citric acid cycle.",
        "B": "Converted to oxaloacetate to replenish the citric acid cycle.",
        "C": "Converted to lactate by lactate dehydrogenase to regenerate NAD + .",
        "D": "Converted to alanine via transamination."
      },
      "correct_answer": "C",
      "explanation": "cell. In low energy state: In a low-energy state, the fate of pyruvate depends on the oxygenation of the cell: In aerobic conditions: In anaerobic conditions: In the presence of oxygen, aerobic respiration will continue. In the absence of oxygen, anaerobic glycolysis takes place. Pyruvate, which is produced at the end of glycolysis, is transported to mitochondria. It takes place in mitochondria deficit cells such as RBCs and neurons and also in muscle cells during exercise (Option C) In mitochondria, pyruvate combines with coenzyme A to produce Acetyl CoA, which enters the citric acid pathway (Option A ruled out). In these cells, pyruvate is converted to lactate by lactate dehydrogenase, using NADH to regenerate NAD + , which is necessary for ATP production. The byproducts of this reaction include CO2 and NADH The byproduct is NAD+. Converted to oxaloacetate to replenish the citric acid cycle (Option B): Oxaloacetate conversion by pyruvate carboxylase mainly occurs in liver and kidney cells, replenishing the citric acid cycle under in high energy state (not in anaerobic conditions). However, RBCs lack mitochondria and do not undergo this conversion. Converted to alanine via transamination (Option D): Pyruvate can be converted to alanine via transamination, which is seen in the high-energy state of cells.",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxbiochemistry/Complex_Electron_Transport_Chain_Q1_exp.png",
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 2,
      "question": "Which of the following metabolic disturbances is most likely to be seen in a patient with pyruvate dehydrogenase deficiency?",
      "options": {
        "A": "Hypoglycemia due to impaired gluconeogenesis.",
        "B": "Hyperglycemia due to increased gluconeogenesis.",
        "C": "Ketoacidosis due to excessive fatty acid oxidation.",
        "D": "Lactic acidosis due to impaired conversion of pyruvate to acetyl-CoA."
      },
      "correct_answer": "D",
      "explanation": "which is inherited in an X-linked pattern. PDH deficiency leads to impaired conversion of pyruvate to acetyl CoA. As a result, pyruvate accumulates in the tissues and is shunted towards lactate production, leading to lactic acidosis, particularly after glucose load, a hallmark of PDH deficiency (Option D). Glucose levels are normal (Options A&B ruled out) Clinical features include nausea, vomiting, neurologic problems such as ataxia, intellectual disability, seizures, hypotonia, and poor coordination. Treatment is based on stimulating PDH with cofactor supplementation such as thiamine, and lipoic acid. Ketoacidosis due to excessive fatty acid oxidation (Option C): Ketoacidosis is more commonly associated with conditions like diabetic ketoacidosis or inborn errors of metabolism involving fatty acid oxidation, not PDH deficiency. PDH deficiency also presents with ketoacidosis, but the most likely presentation is lactic acidosis",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxbiochemistry/Complex_Electron_Transport_Chain_Q2_exp.jpg",
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 3,
      "question": "During fasting, after how many hours does gluconeogenesis become the primary source of blood glucose?",
      "options": {
        "A": "8 to 12 hours",
        "B": "12 to 24 hours",
        "C": "16 to 48 hours",
        "D": "48 to 72 hours"
      },
      "correct_answer": "C",
      "explanation": "depleted. Glycogenolysis maintains blood glucose for the first 12 to 24 hours . After 16 hours , gluconeogenesis gradually increases and becomes the dominant source by 24 to 48 hours . Major substrates include lactate, alanine, and glycerol. During fasting: After 4-16 hrs, the primary source of glucose is glycogenolysis After 16-48 hrs, the primary source of glucose is gluconeogenesis. Gluconeogenesis: It is a process in which glucose is synthesized by non-carbohydrate sources such as amino acids, lactate, glycerol, and propionyl CoA. The major site of gluconeogenesis the liver > kidney. Regulation of gluconeogenesis: Glucagon activates fructose 1,6-bisphosphatase and inhibits PFK-1, favoring gluconeogenesis and inhibiting glycolysis The availability of substrates such as alanine, lactate, and glycerol favors gluconeogenesis Acetyl CoA is an allosteric activator of 1st regulatory step of gluconeogenesis (pyruvate carboxylase) 8 to 12 hours (Option A): Incorrect because glycogenolysis is still the primary source of glucose at this stage. 12 to 24 hours (Option B): Incorrect because gluconeogenesis is only starting to rise, but glycogenolysis is still significant. 48 to 72 hours (Option D): Incorrect because gluconeogenesis has already been the dominant glucose source for a long time by this point. Reference: Harperâ€™s Illustrated Biochemistry, Edition 32, Pg 180-189 Lippincott Illustrated Reviews: Biochemistry 7e, pg no: 376-78",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxbiochemistry/Complex_Electron_Transport_Chain_Q3_exp.jpg",
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 4,
      "question": "Which of the following is the primary site for peripheral lipolysis?",
      "options": {
        "A": "Liver",
        "B": "Skeletal muscle",
        "C": "Adipose tissue",
        "D": "Pancreas"
      },
      "correct_answer": "C",
      "explanation": "(FFA) and glycerol. This process is mediated by hormone-sensitive lipase (HSL). This process occurs in adipose tissue (Option C) The lipase acts on triacylglycerols and converts them into diacylglycerol , the preferred substrate for HSL. The glycerol released from the adipose tissue is transported to the liver and participates in glycolysis or gluconeogenesis. Free fatty acids bind to albumin and are transported to muscles, where they are activated into their CoA derivatives and oxidized in mitochondria for ATP. Regulation: HSL is activated when phosphorylated with protein kinase A, which in turn is dependent on cAMP produced in the adipocyte when catecholamines activate adenylyl cyclase. Insulin dephosphorylates HSL and inactivates it. The counter-regulatory hormones of insulin, such as glucagon, epinephrine, and cortisol, stimulate the activity of HSL. Liver (Option A): Incorrect because the liver processes fatty acids but is not the primary site for peripheral lipolysis. Skeletal muscle (Option B): Incorrect because muscle utilizes fatty acids but does not primarily break down triglycerides. Pancreas (Option D): Incorrect because the pancreas regulates metabolism via insulin and glucagon but does not carry out lipolysis.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 5,
      "question": "A 5-year-old boy presents with severe lethargy, vomiting and ataxia for 24 hours. Lab tests show metabolic acidosis, elevated lactate, and pyruvate. Genetic testing confirms pyruvate dehydrogenase complex deficiency. What is the underlying mechanism for his metabolic derangements?",
      "options": {
        "A": "Impaired conversion of pyruvate to acetyl-CoA.",
        "B": "Increased conversion of pyruvate to ribose-5-phosphate.",
        "C": "Reduced activity of the electron transport chain.",
        "D": "Inhibition of gluconeogenesis in the liver."
      },
      "correct_answer": "A",
      "explanation": "acetyl-CoA, a crucial step in aerobic glucose metabolism. A deficiency in this complex leads to the accumulation of pyruvate, which is then shunted towards lactate production, resulting in lactic acidosis. Pyruvate dehydrogenase (PDH) complex: Catalyzes the irreversible conversion of pyruvate to acetyl-CoA in mitochondria. A critical step in aerobic glucose metabolism, as it links glycolysis to the citric acid cycle. Structure : 5 Coenzymes - thiamine pyrophosphate (TPP), lipoic acid, CoA, FAD, and NAD +. 3 products: NADH, CO2, Acetyl-CoA. 3 substrates: Pyruvate, NAD, CoA. 3 subunits: E1 (PDH / PDC), E2 (dihydrolipoyl transacetylase), and E3 (dihydrolipoyl dehydrogenase). Irreversible reaction : Pyruvate to acetyl-CoA is highly exergonic and irreversible, preventing direct synthesis of glucose from acetyl-CoA. Regulation : Inhibition: Acetyl-CoA, NADH, and ATP inhibit PDH to conserve glucose. Phosphorylation: Kinase inactivates, and phosphatase activates PDH based on energy status. Hormonal Control: Insulin activates PDH for fat synthesis Calcium: Activates PDH during muscle contraction. Clinical significance : PDH complex deficiencies are rare but serious genetic disorders causing lactic acidosis, neurological issues, and developmental delays. Thiamine deficiency, common in alcoholics, impairs PDH complex activity, leading to pyruvate accumulation and lactic acidosis. Increased conversion of pyruvate to ribose-5-phosphate (Option B): Pyruvate does not convert to ribose-5-phosphate (R-5-P), which is produced through the pentose phosphate pathway, and it does not involve the PDH complex. The issue is the impaired conversion of pyruvate to acetyl-CoA, not R-5-P production. Reduced activity of the electron transport chain (Option C) is a potential cause of metabolic acidosis. Inhibition of gluconeogenesis in the liver (Option D) would result in hypoglycemia but would not explain the accumulation of lactate and pyruvate.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 6,
      "question": "Which of the following regulatory effects best explains the anti-neoplastic effect of the ketogenic diet?",
      "options": {
        "A": "Acetyl CoA stimulates pyruvate carboxylase.",
        "B": "Malonyl CoA inhibits carnitine acyltransferase-1.",
        "C": "Citrate inhibits PFK1.",
        "D": "Acyl CoA stimulates carnitine acyltransferase-1."
      },
      "correct_answer": "C",
      "explanation": "high fat low carbohydrate diet. his helps in restricting neoplastic growth, as neoplastic cells are dependent on glucose through aerobic glycolysis (Warburg effect). Effect Definition Clinical Significance Glucose-Sparing Effect The inhibition of glucose oxidation by fatty acid oxidation. Neurons and red blood cells exclusively use glucose for fuel. Red and cardiac muscle fibers can utilize glucose or fatty acids. The glucose-sparing effect ensures cardiac muscle prioritizes fatty acids, preserving glucose for neurons and red blood cells. Pasteur Effect he i nhibition of anaerobic glycolysis by aerobic oxidation products. The ketogenic diet limits carbohydrate intake, thereby reducing glucose availability and glycolysis. Lower pyruvate reduces citric acid cycle activity. Increased fatty acid oxidation raises acetyl-CoA, forming citrate. Citrate inhibits PFK-1, suppressing glycolysis and limiting glucose use by neoplasia. Warburg Effect The phenomenon in cancer cells where, even in the presence of oxygen, glucose is primarily converted to lactate through aerobic glycolysis. This allows faster ATP production and provides intermediates for neoplastic cell growth and multiplication. It increases NADPH production, protecting neoplastic cells from oxidative stress. Acetyl-CoA stimulates pyruvate carboxylase (Option A): While acetyl- CoA does stimulate pyruvate carboxylase, this process increases glucose levels, which is counterproductive for someone with neoplasia. Malonyl-CoA inhibits carnitine acyltransferase-1 (Option B): This is related to fatty acid oxidation but is not directly involved in the antineoplastic effect of a ketogenic diet. Acyl CoA stimulates carnitine acyltransferase-1 (Option D): This is related to fatty acid oxidation but is not directly involved in the antineoplastic effect of a ketogenic diet. Reference: Pasteur Effect Warburg Effect Glucose Sparing Effect",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 7,
      "question": "A 25-year-old athlete presents with exercise intolerance and muscle fatigue, particularly during high-intensity training. Genetic testing reveals a deficiency in the enzyme that facilitates the transfer of electrons from cytosolic NADH to mitochondrial FADH 2 in skeletal muscle. Which shuttle system is likely impaired in this athlete?",
      "options": {
        "A": "Malate shuttle",
        "B": "Glycerol phosphate shuttle",
        "C": "Citrate shuttle",
        "D": "Aspartate shuttle"
      },
      "correct_answer": "B",
      "explanation": "electrons from cytosolic NADH to mitochondrial FADH 2 Electron Transport Chain (ETC): Location : I nner mitochondrial membrane. The ADP-ATP translocase in the inner mitochondrial membrane exports ATP to the cytosol and imports ADP into the mitochondria.. Atractyloside inhibits this transport process. Function : It plays a crucial role in oxidative phosphorylation. Oxidation, which involves the loss of electrons, is central to this process and drives ATP synthesis Shuttles : NADH Shuttles: Glycolysis, which occurs in the cytoplasm, generates 2 NADH molecules per glucose molecule. NADH cannot directly cross the mitochondrial membrane; it requires shuttles for transport. There are two main shuttle systems: the malate-aspartate shuttle (Image 1) and the glycerol phosphate shuttle (Image 2), which facilitate NADH transport across the mitochondrial membrane Property Malate Shuttle (Option A ruled out) Glycerol Phosphate Shuttle Location Present in most cells except white muscle fibers and neurons. White muscle fibers and neurons Energy \"No net ATP loss\" â†’ Consumes 2 ATP per glucose molecule. Loss of 2 ATPs per glucose molecule Electron Carrier Electron Carrier: Transfers electrons to mitochondrial NADH, maintaining cytosolic NAD+/NADH balance. Transfers electrons to mitochondrial FADH2 Enzymes Cytoplasmic and mitochondrial glycerol-3-phosphate dehydrogenase. Cytoplasmic & mitochondrial glycerol-3-phosphate dehydrogenase Citrate shuttle (Option C) transports acetyl-CoA from the mitochondria to the cytosol for fatty acid synthesis, not for transferring electrons from NADH to FADH2. The aspartate shuttle (Option D) , also known as the malate-aspartate shuttle, is involved in transferring electrons from cytosolic NADH to mitochondrial NADH.",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxbiochemistry/Complex_Electron_Transport_Chain_Q7_exp.png",
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 8,
      "question": "Which of the following statements regarding the electron transport chain (ETC) is incorrect?",
      "options": {
        "A": "Electrons from NADH enter the ETC through Complex I",
        "B": "Complex II is the only complex that does not pump protons.",
        "C": "Coenzyme Q and cytochrome c transfer electrons between complexes",
        "D": "Complex IV is the only complex that contains iron-sulfur proteins."
      },
      "correct_answer": "D",
      "explanation": "c oxidase), which contains copper instead. Complex Name Electron Donor Electron Acceptor Protons Pumped Complex I NADH dehydrogenase NADH Coenzyme Q (or Ubiquinone) 4 Complex II Succinate dehydrogenase Succinate (FADH2) Coenzyme Q 0 Complex III (Cytochrome b & c1) Q-cytochrome c oxidoreductase Coenzyme Q (QH2) Cytochrome C 4 Complex IV (Cytochrome a & a3) Cytochrome c oxidase Cytochrome C Oxygen 2 Complex V ATP Synthase Complex V consists of two main parts: The F I portion, which is embedded in the membrane and transports protons, and the F I portion , which catalyzes ATP formation from ADP and Pi. Electrons from NADH enter the ETC through Complex I (Option A): Correct because NADH transfers electrons to Complex I, initiating the electron transport chain. Complex II is the only complex that does not pump protons (Option B): Correct because Complex II transfers electrons to Coenzyme Q but does not contribute to proton pumping. Coenzyme Q and cytochrome c transfer electrons between complexes (Option C): Correct because these mobile carriers shuttle electrons between different complexes. Reference: Harperâ€™s Illustrated Biochemistry, 32nd edition, pg: 122-123.",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxbiochemistry/Complex_Electron_Transport_Chain_Q8_exp.jpg",
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 9,
      "question": "A patient, with a history of attempting weight loss, presents with fatigue, muscle weakness, and vision problems. Genetic testing confirms MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke). Which electron transport chain complex is most likely affected in this patient",
      "options": {
        "A": "Complex I",
        "B": "Complex II",
        "C": "Complex III",
        "D": "Complex V"
      },
      "correct_answer": "A",
      "explanation": "mutations in mitochondrial DNA, primarily affecting Complex I of the electron transport chain. Complex I (NADH dehydrogenase) is responsible for transferring electrons from NADH to Coenzyme Q, initiating the ETC and contributing to ATP production. Dysfunction in Complex I leads to impaired oxidative phosphorylation, decreased ATP generation, and increased lactic acid levels , contributing to the metabolic abnormalities seen in MELAS. Symptoms such as fatigue, muscle weakness, and neurological issues (including vision problems and stroke-like episodes) result from energy deficiency in high-demand tissues like muscles and the brain. Electron Transport Chain Defects in Mitochondrial Disorders Complex Role in ETC Association with Disease Complex I (NADH dehydrogenase) Transfers electrons from NADH to Coenzyme Q MELAS, Leber's Hereditary Optic Neuropathy (LHON) Complex II (Succinate dehydrogenase) Transfers electrons from FADH I to Coenzyme Q Rarely affected in mitochondrial diseases Complex III (Cytochrome bc I complex) Transfers electrons from Coenzyme Q to cytochrome c Rare disorders (e.g., Mitochondrial Complex III deficiency) Complex IV (Cytochrome c oxidase) Transfers electrons from cytochrome c to oxygen Mitochondrial disorders like Leigh syndrome Complex V (ATP synthase) Synthesizes ATP from proton gradient Neuromuscular disorders, Leigh syndrome Complex II (Option B): Incorrect because Complex II mutations are not a major cause of MELAS. It primarily functions in the Krebs cycle and does not contribute significantly to mitochondrial DNA-related disorders. Complex III (Option C): Incorrect because MELAS is not typically caused by defects in Complex III. Mutations here are rare and usually cause other mitochondrial myopathies. Complex V (Option D): Incorrect because Complex V (ATP synthase) is responsible for ATP production but is not directly linked to MELAS , which primarily affects electron transport. Reference: Harperâ€™s Illustrated Biochemistry, 32nd edition, pg: 127, 130",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 10,
      "question": "In the electron transport chain, how many ATP molecules are produced per NADH and FADH 2 , respectively? How many protons (H+) are translocated across the inner mitochondrial membrane for each?",
      "options": {
        "A": "2.5 ATP per NADH and 1.5 ATP per FADH 2 ; with 10 H + and 6 H + translocated, respectively.",
        "B": "3 ATP per NADH and 2 ATP per FADH 2 ; with 12 H + and 8 H + translocated, respectively.",
        "C": "2 ATP per NADH and 1 ATP per FADH 2 ; with 8 H + and 4 H + translocated, respectively.",
        "D": "1 ATP per NADH and 0.5 ATP per FADH 2 ; with 6 H + and 3 H + translocated, respectively."
      },
      "correct_answer": "A",
      "explanation": "translocated, respectively. I ions are pumped into the intermembrane space, increasing the positive potential. This proton pumping drives ATP production via the ATP synthase complex. ATP synthase produces 1 ATP per 4 H I ions passing through the F I component. Since 4 H I generate 1 ATP, 10 H I generate 2.5 ATP. Therefore, NADH yields 2.5 ATP. NADH , which pumps 4 protons from Complex I, 4 from Complex III, and 2 from Complex IV, generates approximately 2.5 ATP. FADH I , which pumps 4 protons from Complex III and 2 from Complex IV (but none from Complex II) , generates approximately 1.5 ATP. ATP \" data-author=\"\" data-hash=\"7845\" data-license=\"\" data-source=\"\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/FAFmQMgNp63yz2l8n9Zx1744009893.png\" /> Reference: Harperâ€™s Illustrated Biochemistry, 32nd edition, Page: 126",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxbiochemistry/Complex_Electron_Transport_Chain_Q10_exp.png",
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 11,
      "question": "The image below shows the sites of action for different ETC inhibitors. Based on the image, which of the following is the site of action of Cyanide?",
      "options": {
        "A": "A",
        "B": "E",
        "C": "C",
        "D": "D"
      },
      "correct_answer": "D",
      "explanation": "oxygen, disrupting the electron transport chain and reducing ATP production, potentially causing cellular damage. Inhibitors of the Electron Transport Chain (ETC): Inhibitor Target Site Mechanism Rotenone Amobarbital Piericidin A Complex I (Option A ruled out) (NADH dehydrogenase) Blocks electron transfer from NADH in Complex I to ubiquinone. TTFA (Thenoyltrifluoroacetone) Carboxin Complex II (Succinate dehydrogenase) Blocks electron transfer from Complex II to ubiquinone I Malonate Complex II Blocks Complex II activity via competitive inhibition. Antimycin A BAL Complex III (Option C ruled out) Cytochrome bc1 complex Blocks electron transfer from Complex III to cytochrome C. Cyanide (CN âˆ’ ) Carbon monoxide (CO) Hydrogen Sulfide (H2S) Complex IV (Option D) (Cytochrome c Oxidase) Inhibits electron transfer from Complex IV to oxygen, halting respiration. Oligomycin ATP Synthase (Complex V) (Option B ruled out) Inhibits the proton channel of ATP synthase, preventing ATP formation. Atractyloside Adenine Nucleotide Translocase Blocks ADP/ATP exchange across the mitochondrial membrane I Note: ADP to ATP conversion is inhibited by: Oligomycin ADP to ATP transfer is inhibited by: Atractyloside",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxbiochemistry/Complex_Electron_Transport_Chain_Q11_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 12,
      "question": "Which of the following is a physiological uncoupler?",
      "options": {
        "A": "2,4-dinitrophenol",
        "B": "Uncoupling protein 1 [UCP1]",
        "C": "Valinomycin",
        "D": "Nigericin"
      },
      "correct_answer": "B",
      "explanation": "Uncouplers: In the electron transport chain (ETC), oxidation (electron flow) and phosphorylation (ATP formation) are normally coupled. Uncouplers disrupt this coupling, allowing electron transport to occur without ATP synthesis. Mechanism of Uncoupling: Uncouplers act as ion channels in the inner mitochondrial membrane (IMM), allowing protons (H I ) to bypass ATP synthase. Energy from proton movement is released as heat rather than being used for ATP synthesis. Effects of Uncouplers: No ATP production, increased heat production, and increased basal metabolic rate (BMR). Physiological uncouplers Artificial uncouplers Present in brown adipose tissue Aid in thermogenesis in newborns Stimulated by hormones such as thyroxine Ex: Thermogenin (UCP1) (Option B) Thyroxine Free fatty acids (long chain) These were once used as anti-obesity drugs. Ex: 2,4 Dinitrophenol (Option A ruled out) Valinomycin (Option C ruled out) Nigericin (Option D ruled out) High dose aspirin Non-Shivering Thermogenesis: Brown adipose tissue contains abundant mitochondria with uncoupling proteins (thermogenin/UCP1), facilitating non-shivering thermogenesis, which is crucial for heat production in neonates and hibernating animals. Reference: Harperâ€™s Illustrated Biochemistry, 32nd edition, pg: 127, 128. Vasudevanâ€™s Textbook of Biochemistry for Medical Students, Ed 7, Pg. 19 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC316328/",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxbiochemistry/Complex_Electron_Transport_Chain_Q12_exp.png",
      "chapter_heading": "Complex Electron Transport Chain"
    },
    {
      "q_no": 13,
      "question": "A 28-year-old woman presents with recurrent episodes of neurologic disturbances and lactic acidosis, particularly after carbohydrate-rich meals. Genetic testing reveals a mutation affecting one of the components of the pyruvate dehydrogenase complex. Which of the following is most likely to be directly affected by this mutation?",
      "options": {
        "A": "Flavin adenine dinucleotide (FAD)",
        "B": "Dihydrolipoyl transacetylase",
        "C": "Thiamine diphosphate",
        "D": "Coenzyme A"
      },
      "correct_answer": "B",
      "explanation": "complex. The pyruvate dehydrogenase complex consists of three enzyme components : pyruvate dehydrogenase (E1), dihydrolipoyl transacetylase (E2), and dihydrolipoyl dehydrogenase (E3) . A genetic mutation in any of these enzymes can cause pyruvate dehydrogenase deficiency, leading to lactic acidosis. Patients with inherited pyruvate dehydrogenase deficiency, caused by defects in one or more components of the enzyme complex, develop lactic acidosis, especially after a glucose load. Because the brain relies on glucose as its primary energy source, these metabolic defects often lead to neurological impairments Flavin adenine dinucleotide (FAD) (Option A): s a coenzyme involved in the pyruvate dehydrogenase complex reaction, but it is not a protein component. Thiamin diphosphate (Option C) is a cofactor, not a protein component of the complex. Pyruvate dehydrogenase (E1) catalyzes pyruvate decarboxylation, forming a hydroxyethyl-thiamin diphosphate intermediate. Coenzyme A (Option D) is a cofactor, not a protein component of the complex. It accepts the acetyl group from acetyl-lipoamide, forming acetyl-CoA and reduced lipoamide. Reference: Harperâ€™s Illustrated Biochemistry, 32nd edition, pg: 168.",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxbiochemistry/Complex_Electron_Transport_Chain_Q13_exp.jpg",
      "chapter_heading": "Complex Electron Transport Chain"
    }
  ]
}
